Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 11:12 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2785–2808 of 6,645 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Small Groups Clear all

Conditions: Bacterial Infections
Interventions: Eravacycline (TP-434); Drug
Lead sponsor: Tetraphase Pharmaceuticals, Inc; Industry
Eligibility: 8 Years to 17 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 7
States / cities: Los Angeles, California • Chicago, Illinois • Shreveport, Louisiana + 4 more

Conditions: Irritable Bowel Syndrome Characterized by Constipation
Interventions: Linaclotide 290 micrograms, Matching placebo; Drug
Lead sponsor: Forest Laboratories; Industry
Eligibility: 18 Years and older
Enrollment: 803 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 111
States / cities: Birmingham, Alabama • Hueytown, Alabama • Huntsville, Alabama + 94 more

Conditions: Sedentary Behavior / Physical Inactivity, Aged
Interventions: Wearable Ankle Power Training (WearAPT), Control; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 60 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 2
States / cities: Flagstaff, Arizona • Chapel Hill, North Carolina

Conditions: Castration Resistant Prostatic Cancer, Metastatic Prostate Cancer
Interventions: Pembrolizumab, Chemotherapy; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older · Male only
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Anxiety
Interventions: Music in combination with mindfulness; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Coral Gables, Florida

Conditions: Gastro-Oesophageal Cancer
Interventions: Regorafenib, Nivolumab, Docetaxel, Paclitaxel, Irinotecan, Trifluridine/Tipracil; Drug · Biological
Lead sponsor: Australasian Gastro-Intestinal Trials Group; Network
Eligibility: 18 Years and older
Enrollment: 462 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 6
States / cities: Scottsdale, Arizona • Los Angeles, California • Sioux City, Iowa + 3 more

Conditions: Pregnancy Termination in Second Trimester
Interventions: Nitrous Oxide, IV Saline; Drug
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years and older · Female only
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 2
States / cities: Denver, Colorado • Albuquerque, New Mexico

Conditions: Cerebral Palsy
Interventions: Walk Aide training; Device
Lead sponsor: Blythedale Children's Hospital; Other
Eligibility: 8 Years to 17 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 1
States / cities: Valhalla, New York

Conditions: Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Stage IB2 Cervical Cancer FIGO 2018, Stage IB3 Cervical Cancer FIGO 2018, Stage II Cervical Cancer FIGO 2018, Stage IIA Cervical Cancer FIGO 2018, Stage IIA1 Cervical Cancer FIGO 2018, Stage IIA2 Cervical Cancer FIGO 2018, Stage IIB Cervical Cancer FIGO 2018, Stage IIIA Cervical Cancer FIGO 2018, Stage IIIB Cervical Cancer FIGO 2018
Interventions: Media Intervention, Quality-of-Life Assessment, Questionnaire Administration, Survey Administration, Yoga; Other · Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Parkinson Disease
Interventions: Social Cycling Group; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 45 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Anxiety and Mood Disorders
Interventions: Compassion Meditation (CM) intervention, Healthy Aging Psychoeducation; Behavioral · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 55 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: San Diego, California

Conditions: Obstructive Sleep Apnea
Interventions: Rozerem (Ramelteon), Lunesta (Eszopiclone), Historical Controls; Drug · Other
Lead sponsor: Southern California Institute for Research and Education; Other
Eligibility: 18 Years to 65 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Long Beach, California

Conditions: Stroke
Interventions: transcranial random noise stimulation and functional electrical stimulation facilitated task practice; Device
Lead sponsor: Amit Sethi; Other
Eligibility: 18 Years to 80 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Aggression
Interventions: Videos, Bumper stickers, Alcohol-related cues, Music, Roadside vegetation, Video game; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 85 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2025
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Bacterial Infection, Multiple-drug Resistance, Pathogen Resistance
Interventions: Fosfomycin disodium; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 45 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Radial Artery Incision Site Closure
Interventions: TR Band 60MIN, TR Band 120MIN; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Suicidal Ideation
Interventions: Compassion meditation (CM), Support group (SG); Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 64 Years
Enrollment: 456 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2021
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Obesity
Interventions: Active Intervention - Cooking, Demonstrations - Cooking; Behavioral
Lead sponsor: University of Vermont; Other
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Untreated Childhood Medulloblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
Interventions: cisplatin, cyclophosphamide, vincristine sulfate, etoposide, therapeutic conventional surgery, 3-dimensional conformal radiation therapy; Drug · Procedure · Radiation
Lead sponsor: Children's Oncology Group; Network
Eligibility: Up to 3 Years
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2000
U.S. locations: 1
States / cities: Arcadia, California

Conditions: Combined Multicomponent Exercise and Tai Chi
Interventions: Combined multicomponent exercise and Tai Chi; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 65 Years to 95 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Pregnancy Related
Interventions: Focus Group; Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Timeline: 2018
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Physical Disability
Interventions: Removing Environmental Barriers to Independent Living (REBIL), Waitlist Attentional Control; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 45 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: Capnometry-Assisted Training for COPD to Slow the Breath (CATCH), Pulmonary Rehabilitation (PR); Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 40 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Mild Traumatic Brain Injury
Interventions: BCTT, Dynamic ExIT; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 14 Years to 17 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Search by objective public record fields.

A Safety and PK Study of IV Eravacycline

Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation

Wearable Ankle Power Training (WearAPT) for Enhanced Mobility in Aging

Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects

Effect of Music and Mindfulness Meditation

RegoNivo vs Standard of Care Chemotherapy in AGOC

Nitrous Oxide Versus Intravenous Sedation for Anesthesia

Investigating the Use of the WalkAide on a Child's Ability to Ascend/Descend Stairs and Curbs

Yoga Therapy During Chemotherapy and Radiation Treatment for the Improvement of Physical and Emotional Well-Being in Patients With Stage IB2-IIIB Cervical Cancer

In-home Cycling for Individuals With PD: Feasibility

Compassion Meditation for Older Adults

Hypnotics to Improve Polysomnography Yield: Eszopiclone vs Ramelteon?

t-RNS After Hand Recovery in Chronic Stroke

Aggressive Driving and Road Rage: A Driving Simulation Experiment.

Intravenous Fosfomycin Pharmacokinetics Study

Transradial-Band Pilot Study

Compassion Meditation and ReliefLink App for Suicidal, Low-Income, African Americans

Examining Cooking as a Health Behavior

Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor

Tai Chi Interventions on Physical Functions Among Older Adults

Finding Opportunities for Clinical Care and Trial Participation Among Underrepresented Samples

Aging With Long Term Physical Disabilities

Capnometry-Assisted Breathing Training for COPD

Post-Concussion Differences Between Buffalo Concussion Treadmill Test (BCTT) and Modified Dynamic Exertion (mEXiT) Test